In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs—a systematic review and meta-analysis
Authors:
- 6 October 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 49 (6) , 948-958
Abstract
Background: the prevalence of adverse drug reactions (ADRs) in hospitalised older patients, their clinical presentations, causative drugs, severity, preventability and measurable outcomes are unclear, ADRs being an increasing challenge to older patient safety. Methods: we systematically searched PubMed, Embase, EBSCO-CINAHL, the Cochrane Library, ‘rey’ literature and relevant systematic review bibliographies, published from database inception to March 2020. We included any study reporting occurrence of in-hospital ADRs as primary or secondary outcomes in hospitalised older adults (mean age ≥ 65 years). Two authors independently extracted relevant information and appraised studies for bias. Study characteristics, ADR clinical presentations, causative drugs, severity, preventability and clinical outcomes were analysed. Study estimates were pooled using random-effects meta-analytic models. Results: from 2,399 abstracts, we undertook full-text screening in 286, identifying 27 studies (29 papers). Final analysis yielded a pooled ADR prevalence of 16% (95%CI 12–22%, I2 98%,τ2 0.8585), in a population of 20,153 hospitalised patients aged ≥65 years of whom 2,479 patients experienced ≥ one ADR. ADR ascertainment was highly heterogeneous. Almost 48.3% of all ADRs involved five presentations: fluid/electrolyte disturbances (17.3%), gastrointestinal motility/defaecation disorders (13.3%), renal disorders (8.2%), hypotension/blood pressure dysregulation disorders/shock (5.5%) and delirium (4.1%). Four drug classes accounted for 57.8% of causative medications i.e. diuretics (19.8%), anti-bacterials (14.8%), antithrombotic agents (12.2%) and analgesics (10.9%). Pooled analysis of severity was not feasible. Four studies reported the majority of ADRs as preventable (55–95%). Conclusions: on average, 16% of hospitalised older patients experience significant ADRs, varying in severity and mostly preventable, with commonly prescribed drug classes accounting for most ADRs.Keywords
Funding Information
- European Commission (634238)
This publication has 22 references indexed in Scilit:
- Development and Validation of a Risk Model for Predicting Adverse Drug Reactions in Older People during Hospital Stay: Brighton Adverse Drug Reactions Risk (BADRI) ModelPLOS ONE, 2014
- Adverse drug reactions in older patients: an Italian observational prospective hospital studyDrug, Healthcare and Patient Safety, 2012
- Adverse drug reactions in older patients during hospitalisation: are they predictable?Age and Ageing, 2012
- Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitalsJournal of Postgraduate Medicine, 2011
- The DoTS classification is a useful way to classify adverse drug reactions: a preliminary study in hospitalized patientsInternational Journal of Pharmacy Practice, 2010
- Development and Validation of a Score to Assess Risk of Adverse Drug Reactions Among In-Hospital Patients 65 Years or OlderArchives of internal medicine (1960), 2010
- Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patientsPharmacoepidemiology and Drug Safety, 2010
- Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-EpisodesPLOS ONE, 2009
- A prospective study of adverse drug reactions in a dermatology departmentMethods and Findings in Experimental and Clinical Pharmacology, 2007
- ADVERSE DRUG REACTIONS: AN INVESTIGATION ON AN ACUTE GERIATRIC WARDAge and Ageing, 1986